Monday, 12 January 2015

AstraZeneca in cancer viruses deal with Omnis Pharmaceuticals

LONDON (Reuters) - AstraZeneca said on Monday its MedImmune biotech unit had struck a deal with unlisted U.S. company Omnis Pharmaceuticals on the development of cancer-fighting oncolytic viruses.


via Reuters: Health News Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)